🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Validity and Reliability of the Turkish Version of the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ)

Recruitingn/aAges 18 Years - anyAllBiruni University
NCT07654504 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this methodological study is to translate the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ) into Turkish, culturally adapt it, and evaluate its validity and reliability for use in adults with brachial plexus birth palsy. The study will include 50 adult participants aged 18 years and older with a diagnosis of brachial plexus birth palsy. Participants will complete the Turkish version of the IMBPIQ, as well as the Disabilities of the Arm, Shoulder and Hand questionnaire and the Short Form-36. The psychometric properties of the Turkish IMBPIQ will be examined using reliability and validity analyses, including internal consistency, test-retest reliability, and construct validity.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Being 18 years of age or older. * Having a diagnosis of brachial plexus birth palsy. * Having the ability to read, write, speak, and understand Turkish. * Agreeing to participate voluntarily in the study and signing the informed consent form. Exclusion Criteria: * Having a neurological disease. * Having another orthopedic problem or a history of trauma in the affected upper extremity. * Having a severe cognitive or communication impairment that may prevent completion of the questionnaires or understanding of the study instructions. * Having a history of systemic disease requiring an acute attack or hospitalization within the last three months. * Being pregnant or being in the postpartum period of less than 6 months.
💊

What it tests

  • Questionnaire Assessment Battery
📍

Where

1 site
Biruni University
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy